DLB - Latest News
Dolby Laboratories, Inc. (DLB), operates in Technology / Software - Application, trades on NYSE.
Market capitalization stands near $5.55B. Trailing twelve-month P/E ratio is 24.32. Beta to the broader market is 0.78.
The article list below shows the most recent DLB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent DLB Headlines
Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
prnewswire.com - Oct 12, 2026
SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc.
Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast
defenseworld.net - Oct 12, 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Report) are both technology companies, but which is t
Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)
defenseworld.net - Oct 7, 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both technology companies, but which is the superior i
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
seekingalpha.com - Oct 5, 2026
Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross mar
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
globenewswire.com - Sep 29, 2026
October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October 20th Meeting with the Division of Neurology Expect
How News Affects DLB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track DLB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked DLB news questions
- What is the latest DLB news headline?
- The most recent DLB headline (Oct 12, 2026) is "Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the DLB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What DLB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual DLB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.